RecruitingNCT03059420

Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies


Sponsor

Boston Children's Hospital

Enrollment

20,000 participants

Start Date

Feb 1, 2004

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to identify genes associated with impaired development and function of the cranial nerves and brainstem, which may result in misalignment of the eyes (strabismus) and related conditions.


Eligibility

Min Age: 1 Day

Plain Language Summary

Simplified for easier understanding

This genetic research study is investigating the causes of strabismus (misaligned eyes) and congenital cranial dysinnervation disorders (CCDDs) — a group of rare conditions where nerves controlling eye, face, and head movements don't develop properly. The Engle Lab at Boston Children's Hospital is collecting genetic samples to find the underlying gene mutations. You may be eligible if... - You were born with a condition affecting eye movement, cranial nerve function, or brainstem-related movement control - You have a congenital (present from birth) form of one of these conditions - You are at least 1 day old (all ages welcome) You may NOT be eligible if... - Your cranial nerve disorder is associated with a known genetic syndrome (such as Saethre-Chotzen syndrome) - Your condition was caused by an acquired event such as trauma, stroke, tumor, or spinal cord injury Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Boston Children's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03059420


Related Trials